208 related articles for article (PubMed ID: 36111327)
1. Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology.
Sinha S; Haque M
Cureus; 2022 Sep; 14(9):e28944. PubMed ID: 36111327
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].
Wu W; Yang JJ; Wan YG; Tu Y; Shi G; Han WB; Liu BH; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):49-55. PubMed ID: 28945024
[TBL] [Abstract][Full Text] [Related]
4. Renal insulin resistance in type 2 diabetes mellitus and progression of chronic kidney disease: potential pathogenic mechanisms.
Alqallaf A; Swan P; Docherty NG
Expert Rev Endocrinol Metab; 2022 Nov; 17(6):523-532. PubMed ID: 36203374
[TBL] [Abstract][Full Text] [Related]
5. The impact of insulin resistance on the kidney and vasculature.
Artunc F; Schleicher E; Weigert C; Fritsche A; Stefan N; Häring HU
Nat Rev Nephrol; 2016 Dec; 12(12):721-737. PubMed ID: 27748389
[TBL] [Abstract][Full Text] [Related]
6. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
7. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
8. Prolonged exposure of mouse and human podocytes to insulin induces insulin resistance through lysosomal and proteasomal degradation of the insulin receptor.
Lay AC; Hurcombe JA; Betin VMS; Barrington F; Rollason R; Ni L; Gillam L; Pearson GME; Østergaard MV; Hamidi H; Lennon R; Welsh GI; Coward RJM
Diabetologia; 2017 Nov; 60(11):2299-2311. PubMed ID: 28852804
[TBL] [Abstract][Full Text] [Related]
9. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk.
Wu J; Dong J; Verzola D; Hruska K; Garibotto G; Hu Z; Mitch WE; Thomas SS
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1210-1227. PubMed ID: 31507080
[TBL] [Abstract][Full Text] [Related]
10. Cellular and molecular aspects of diabetic nephropathy; the role of VEGF-A.
Carranza K; Veron D; Cercado A; Bautista N; Pozo W; Tufro A; Veron D
Nefrologia; 2015; 35(2):131-8. PubMed ID: 26300505
[TBL] [Abstract][Full Text] [Related]
11. Nutrition and Obesity Impacts on Kidney Health.
Wang AY; Kovesdy CP
Contrib Nephrol; 2021; 199():24-42. PubMed ID: 34343991
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
[TBL] [Abstract][Full Text] [Related]
13. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.
Marchelek-Mysliwiec M; Dziedziejko V; Dolegowka K; Pawlik A; Safranow K; Stepniewska J; Wisniewska M; Malyszko J; Ciechanowski K
J Appl Biomed; 2020 Aug; 18(2-3):61-69. PubMed ID: 34907727
[TBL] [Abstract][Full Text] [Related]
14. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.
Ling J; Ng JKC; Chan JCN; Chow E
Front Endocrinol (Lausanne); 2022; 13():869899. PubMed ID: 35528010
[TBL] [Abstract][Full Text] [Related]
15. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function.
Guebre-Egziabher F; Alix PM; Koppe L; Pelletier CC; Kalbacher E; Fouque D; Soulage CO
Biochimie; 2013 Nov; 95(11):1971-9. PubMed ID: 23896376
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in chronic kidney disease: a systematic review.
Spoto B; Pisano A; Zoccali C
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
[TBL] [Abstract][Full Text] [Related]
17. Impaired pulmonary vasomotor control in exercising swine with multiple comorbidities.
van de Wouw J; Steenhorst JJ; Sorop O; van Drie RWA; Wielopolski PA; Kleinjan A; Hirsch A; Duncker DJ; Merkus D
Basic Res Cardiol; 2021 Sep; 116(1):51. PubMed ID: 34510273
[TBL] [Abstract][Full Text] [Related]
18. The Bidirectional Link Between Diabetes and Kidney Disease: Mechanisms and Management.
Kumar M; Dev S; Khalid MU; Siddenthi SM; Noman M; John C; Akubuiro C; Haider A; Rani R; Kashif M; Varrassi G; Khatri M; Kumar S; Mohamad T
Cureus; 2023 Sep; 15(9):e45615. PubMed ID: 37868469
[TBL] [Abstract][Full Text] [Related]
19. Role of Phosphatidylinositol 3-Kinase (PI3K), Mitogen-Activated Protein Kinase (MAPK), and Protein Kinase C (PKC) in Calcium Signaling Pathways Linked to the α
Gutiérrez A; Contreras C; Sánchez A; Prieto D
Front Physiol; 2019; 10():55. PubMed ID: 30787881
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
